Original Article

Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants

Volume 5 · Issue 3 Publish Date: September 15, 2009
Full Text PDF
M. Archontaki
Ear, Nose and Throat Department, General Hospital Of Rethymnon, Crete, Greece
E. K. Symvoulakis
University General Hospital of Heraklion, Crete, Greece
J. K. Hajiioannou
ENT Department of General Hospital of Nikea, Piraeus, Greece
A. K. Stamou
Ear, Nose and Throat Department, General Hospital Of Rethymnon, Crete, Greece
S. Kastrinakis
Ear, Nose and Throat Department, General Hospital Of Rethymnon, Crete, Greece
A. J. Bizaki
Ear, Nose and Throat Department, University General Hospital of Heraklion, Crete, Greece
D. E. Kyrmizakis
Department of Otorhinolaryngology, General Hospital of Rethymno, Crete, Greece
Archontaki, M., Symvoulakis, E. K., Hajiioannou, J. K., Stamou, A. K., Kastrinakis, S., Bizaki, A. J., & Kyrmizakis, D. E. (2009). Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants. B-ENT, 5(3), 159–162. Retrieved from https://www.b-ent.be/index.php/pub/article/view/252
Full Text Full Text PDF

Abstract

Aim: The aim of this study was to investigate the frequency of rhinitis medicamentosa (RM) in patients attending the ENT outpatient clinic of the General Hospital of Rethymnon (Crete, Greece) before and after the launch of an intensive nasal decongestant advertising campaign in Greece. Methods: We reviewed the medical records of the patients with RM seen at the ENT outpatient clinic in May, June and July of 2003 and 2006. We analyzed and recorded the gender, age, and related clinical information of the patients with RM. Results: In May, June and July of 2003, 41 patients out of a total of 1780 patients attending the ENT outpatient clinic were diagnosed with RM (2.3%). In the same months in 2006, 161 patients out a total of 1898 patients were diagnosed with RM (8.5%). The frequency of RM in these groups was therefore found to have increased significantly between 2003 and 2006. In 2006, 8 out of 10 patients with RM reported that they had made their purchasing decision solely on the basis of the information supplied by the drug advertisement without consulting their doctor or pharmacist. Conclusion: We suggest that the intensive media advertising campaign for nasal topical decongestants (particularly on TV) which started in 2004 is probably the main reason for this “endemic” RM.

Similar Articles

Article Info
Published In
Journal B-ENT
Volume / Issue Volume 5 · Issue 3
Pages 159-162
History
Published Online September 15, 2009
Affiliations
M. Archontaki
Ear, Nose and Throat Department, General Hospital Of Rethymnon, Crete, Greece
E. K. Symvoulakis
University General Hospital of Heraklion, Crete, Greece
J. K. Hajiioannou
ENT Department of General Hospital of Nikea, Piraeus, Greece
A. K. Stamou
Ear, Nose and Throat Department, General Hospital Of Rethymnon, Crete, Greece
S. Kastrinakis
Ear, Nose and Throat Department, General Hospital Of Rethymnon, Crete, Greece
A. J. Bizaki
Ear, Nose and Throat Department, University General Hospital of Heraklion, Crete, Greece
D. E. Kyrmizakis
Department of Otorhinolaryngology, General Hospital of Rethymno, Crete, Greece
Cite this Article
Archontaki, M., Symvoulakis, E. K., Hajiioannou, J. K., Stamou, A. K., Kastrinakis, S., Bizaki, A. J., & Kyrmizakis, D. E. (2009). Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants. B-ENT, 5(3), 159–162. Retrieved from https://www.b-ent.be/index.php/pub/article/view/252
Outlines